TG THERAPEUTICS, INC. (TGTX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 173 transactions totaling $26.6M, demonstrating a bearish sentiment with -$21.4M in net insider flow. The most recent transaction on Jan 29, 2026 involved a transaction of 13,197 shares valued at $0.
No significant insider buying has been recorded for TGTX in the recent period.
No significant insider selling has been recorded for TGTX in the recent period.
Based on recent SEC filings, insider sentiment for TGTX is bearish with an Insider Alignment Score of 10/100 and a net flow of -$21.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at TG THERAPEUTICS, INC. (TGTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading TGTX stock, having executed 173 transactions in the past 90 days. The most active insider is Sean A. Power (Executive), who has made 39 transactions totaling $10.1M.
Get notified when executives and directors at TGTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | N. Charney Laurence | Executive | Gift | 13,197 | $N/A | $0 | |
| Jan 28, 2026 | N. Charney Laurence | Executive | Gift | 30,000 | $N/A | $0 | |
| Nov 24, 2025 | Echelard Yann | Executive | Sale | 5,000 | $32.57 | $162.8K | |
| Nov 5, 2025 | S. Weiss Michael | Executive | Gift | 803,717 | $N/A | $0 | |
| Nov 5, 2025 | S. Weiss Michael | Executive | Gift | 3,865,126 | $N/A | $0 | |
| Sep 11, 2025 | Lonial Sagar | Executive | Sale | 20,852 | $32.24 | $672.3K | Large |
| Jun 20, 2024 | Lonial Sagar | Executive | Sale | 16,348 | $16.87 | $275.8K | |
| Jun 19, 2024 | N. Charney Laurence | Executive | Award | 22,250 | $N/A | $0 | |
| Jun 19, 2024 | Echelard Yann | Executive | Award | 22,250 | $N/A | $0 | |
| Jun 19, 2024 | Hoberman Kenneth | Executive | Award | 22,250 | $N/A | $0 | |
| Jun 19, 2024 | Hume Daniel | Executive | Award | 22,250 | $N/A | $0 | |
| Jun 19, 2024 | Lonial Sagar | Executive | Award | 22,250 | $N/A | $0 | |
| Jun 17, 2024 | Lonial Sagar | Executive | Sale | 9,585 | $16.39 | $157.1K | |
| Mar 13, 2024 | Lonial Sagar | Executive | Sale | 5,000 | $15.94 | $79.7K | |
| Mar 12, 2024 | N. Charney Laurence | Executive | Sale | 22,000 | $15.97 | $351.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 40 | $24.0M | 89.6% |
Purchase(P) | 8 | $2.6M | 9.6% |
Payment(F) | 2 | $208.8K | 0.8% |
Gift(G) | 20 | $0 | 0.0% |
Award(A) | 101 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Exercise (Options)(X) | 1 | $0 | 0.0% |
Insider selling pressure at TG THERAPEUTICS, INC. has increased, with 12 insiders executing 173 transactions across all time. Total sales of $24.0M significantly outpace purchases of $2.6M, resulting in a net outflow of $21.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.